Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study.
Bédard A, Basagaña X, Anto JM, Garcia-Aymerich J, Devillier P, Arnavielhe S, Bedbrook A, Onorato GL, Czarlewski W, Murray R, Almeida R, Fonseca J, Costa E, Malva J, Morais-Almeida M, Pereira AM, Todo-Bom A, Menditto E, Stellato C, Ventura MT, Cruz AA, Stelmach R, da Silva J, Larenas-Linnemann D, Fuentes-Pérez JM, Huerta-Villalobos YR, Emuzyte R, Kvedariene V, Valiulis A, Kuna P, Samolinski B, Klimek L, Mösges R, Pfaar O, Shamai S, Annesi-Maesano I, Bosse I, Demoly P, Fontaine JF, Cardona V, Mullol J, Valero A, Roller-Wirnsberger RE, Tomazic PV, Chavannes NH, Fokkens WJ, Reitsma S, Bewick M, Ryan D, Sheikh A, Haahtela T, Toppila-Salmi S, Valovirta E, Makris M, Papadopoulos NG, Prokopakis EP, Psarros F, Cingi C, Gemicioğlu B, Yorgancioglu A, Bosnic-Anticevich S, O'Hehir RE, Bachert C, Hellings PW, Pugin B, Bindslev-Jensen C, Eller E, Kull I, Melén E, Wickman M, De Vries G, van Eerd M, Agache I, Ansotegui IJ, Dykewicz MS, Casale T, Wallace D, Waserman S, Laune D, Bousquet J; MASK study group.
Bédard A, et al. Among authors: melen e.
J Allergy Clin Immunol. 2019 Jul;144(1):135-143.e6. doi: 10.1016/j.jaci.2019.01.053. Epub 2019 Apr 3.
J Allergy Clin Immunol. 2019.
PMID: 30951790
Free article.
